aluates Reports

$ 0.0

Automative

Global LV-Based Cell and Gene Therapy Products Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-0D17310

BUY CHAPTERS

Global LV-Based Cell and Gene Therapy Products Market Research Report 2024

Code: QYRE-Auto-0D17310

Report

April 2024

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Bluebird bio

Thermo Fisher Scientific

Intas

BMS

Orchard Therapeutics

LV-Based Cell and Gene Therapy Products Market

LV-based cell and gene therapy products refer to therapeutic products that utilize lentiviral vectors (LV) as a delivery system for introducing genetic material into target cells. Lentiviral vectors are commonly used in gene therapy to transfer genes into cells for the treatment of genetic disorders, cancer, and other diseases.

The global LV-Based Cell and Gene Therapy Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for LV-Based Cell and Gene Therapy Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for LV-Based Cell and Gene Therapy Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for LV-Based Cell and Gene Therapy Products in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of LV-Based Cell and Gene Therapy Products include Novartis, Bluebird Bio, Thermo Fisher Scientific, Intas, BMS, Orchard Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for LV-Based Cell and Gene Therapy Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LV-Based Cell and Gene Therapy Products.

The LV-Based Cell and Gene Therapy Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global LV-Based Cell and Gene Therapy Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the LV-Based Cell and Gene Therapy Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of LV-Based Cell and Gene Therapy Products Market Report

Report Metric	Details
Report Name	LV-Based Cell and Gene Therapy Products Market
Segment by Type	CAR-T Therapy Autologous CD34+ Cell Gene Therapy
Segment by Application	Hospital Diagnostic and Testing Laboratories Academic and Research Organizations Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Bluebird Bio, Thermo Fisher Scientific, Intas, BMS, Orchard Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LV-Based Cell and Gene Therapy Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the LV-Based Cell and Gene Therapy Products Market report?

Ans: The main players in the LV-Based Cell and Gene Therapy Products Market are Novartis, Bluebird Bio, Thermo Fisher Scientific, Intas, BMS, Orchard Therapeutics

What are the Application segmentation covered in the LV-Based Cell and Gene Therapy Products Market report?

Ans: The Applications covered in the LV-Based Cell and Gene Therapy Products Market report are Hospital, Diagnostic and Testing Laboratories, Academic and Research Organizations, Others

What are the Type segmentation covered in the LV-Based Cell and Gene Therapy Products Market report?

Ans: The Types covered in the LV-Based Cell and Gene Therapy Products Market report are CAR-T Therapy, Autologous CD34+ Cell Gene Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 CAR-T Therapy

1.2.3 Autologous CD34+ Cell Gene Therapy

1.3 Market by Application

1.3.1 Global LV-Based Cell and Gene Therapy Products Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Diagnostic and Testing Laboratories

1.3.4 Academic and Research Organizations

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global LV-Based Cell and Gene Therapy Products Market Perspective (2019-2030)

2.2 Global LV-Based Cell and Gene Therapy Products Growth Trends by Region

2.2.1 Global LV-Based Cell and Gene Therapy Products Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 LV-Based Cell and Gene Therapy Products Historic Market Size by Region (2019-2024)

2.2.3 LV-Based Cell and Gene Therapy Products Forecasted Market Size by Region (2025-2030)

2.3 LV-Based Cell and Gene Therapy Products Market Dynamics

2.3.1 LV-Based Cell and Gene Therapy Products Industry Trends

2.3.2 LV-Based Cell and Gene Therapy Products Market Drivers

2.3.3 LV-Based Cell and Gene Therapy Products Market Challenges

2.3.4 LV-Based Cell and Gene Therapy Products Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top LV-Based Cell and Gene Therapy Products Players by Revenue

3.1.1 Global Top LV-Based Cell and Gene Therapy Products Players by Revenue (2019-2024)

3.1.2 Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Players (2019-2024)

3.2 Global LV-Based Cell and Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by LV-Based Cell and Gene Therapy Products Revenue

3.4 Global LV-Based Cell and Gene Therapy Products Market Concentration Ratio

3.4.1 Global LV-Based Cell and Gene Therapy Products Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by LV-Based Cell and Gene Therapy Products Revenue in 2023

3.5 Global Key Players of LV-Based Cell and Gene Therapy Products Head office and Area Served

3.6 Global Key Players of LV-Based Cell and Gene Therapy Products, Product and Application

3.7 Global Key Players of LV-Based Cell and Gene Therapy Products, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 LV-Based Cell and Gene Therapy Products Breakdown Data by Type

4.1 Global LV-Based Cell and Gene Therapy Products Historic Market Size by Type (2019-2024)

4.2 Global LV-Based Cell and Gene Therapy Products Forecasted Market Size by Type (2025-2030)

5 LV-Based Cell and Gene Therapy Products Breakdown Data by Application

5.1 Global LV-Based Cell and Gene Therapy Products Historic Market Size by Application (2019-2024)

5.2 Global LV-Based Cell and Gene Therapy Products Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America LV-Based Cell and Gene Therapy Products Market Size (2019-2030)

6.2 North America LV-Based Cell and Gene Therapy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024)

6.4 North America LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe LV-Based Cell and Gene Therapy Products Market Size (2019-2030)

7.2 Europe LV-Based Cell and Gene Therapy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024)

7.4 Europe LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size (2019-2030)

8.2 Asia-Pacific LV-Based Cell and Gene Therapy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024)

8.4 Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America LV-Based Cell and Gene Therapy Products Market Size (2019-2030)

9.2 Latin America LV-Based Cell and Gene Therapy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024)

9.4 Latin America LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size (2019-2030)

10.2 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024)

10.4 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis LV-Based Cell and Gene Therapy Products Introduction

11.1.4 Novartis Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024)

11.1.5 Novartis Recent Development

11.2 Bluebird Bio

11.2.1 Bluebird Bio Company Details

11.2.2 Bluebird Bio Business Overview

11.2.3 Bluebird Bio LV-Based Cell and Gene Therapy Products Introduction

11.2.4 Bluebird Bio Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024)

11.2.5 Bluebird Bio Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Introduction

11.3.4 Thermo Fisher Scientific Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 Intas

11.4.1 Intas Company Details

11.4.2 Intas Business Overview

11.4.3 Intas LV-Based Cell and Gene Therapy Products Introduction

11.4.4 Intas Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024)

11.4.5 Intas Recent Development

11.5 BMS

11.5.1 BMS Company Details

11.5.2 BMS Business Overview

11.5.3 BMS LV-Based Cell and Gene Therapy Products Introduction

11.5.4 BMS Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024)

11.5.5 BMS Recent Development

11.6 Orchard Therapeutics

11.6.1 Orchard Therapeutics Company Details

11.6.2 Orchard Therapeutics Business Overview

11.6.3 Orchard Therapeutics LV-Based Cell and Gene Therapy Products Introduction

11.6.4 Orchard Therapeutics Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024)

11.6.5 Orchard Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Bluebird bio

Thermo Fisher Scientific

Intas

BMS

Orchard Therapeutics

List of Tables

Table 1. Global LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of CAR-T Therapy

Table 3. Key Players of Autologous CD34+ Cell Gene Therapy

Table 4. Global LV-Based Cell and Gene Therapy Products Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global LV-Based Cell and Gene Therapy Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global LV-Based Cell and Gene Therapy Products Market Share by Region (2019-2024)

Table 8. Global LV-Based Cell and Gene Therapy Products Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global LV-Based Cell and Gene Therapy Products Market Share by Region (2025-2030)

Table 10. LV-Based Cell and Gene Therapy Products Market Trends

Table 11. LV-Based Cell and Gene Therapy Products Market Drivers

Table 12. LV-Based Cell and Gene Therapy Products Market Challenges

Table 13. LV-Based Cell and Gene Therapy Products Market Restraints

Table 14. Global LV-Based Cell and Gene Therapy Products Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global LV-Based Cell and Gene Therapy Products Market Share by Players (2019-2024)

Table 16. Global Top LV-Based Cell and Gene Therapy Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LV-Based Cell and Gene Therapy Products as of 2023)

Table 17. Ranking of Global Top LV-Based Cell and Gene Therapy Products Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by LV-Based Cell and Gene Therapy Products Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of LV-Based Cell and Gene Therapy Products, Headquarters and Area Served

Table 20. Global Key Players of LV-Based Cell and Gene Therapy Products, Product and Application

Table 21. Global Key Players of LV-Based Cell and Gene Therapy Products, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Type (2019-2024)

Table 25. Global LV-Based Cell and Gene Therapy Products Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Type (2025-2030)

Table 27. Global LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Application (2019-2024)

Table 29. Global LV-Based Cell and Gene Therapy Products Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Application (2025-2030)

Table 31. North America LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Country (2025-2030) & (US$ Million)

Table 46. Novartis Company Details

Table 47. Novartis Business Overview

Table 48. Novartis LV-Based Cell and Gene Therapy Products Product

Table 49. Novartis Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024) & (US$ Million)

Table 50. Novartis Recent Development

Table 51. Bluebird Bio Company Details

Table 52. Bluebird Bio Business Overview

Table 53. Bluebird Bio LV-Based Cell and Gene Therapy Products Product

Table 54. Bluebird Bio Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024) & (US$ Million)

Table 55. Bluebird Bio Recent Development

Table 56. Thermo Fisher Scientific Company Details

Table 57. Thermo Fisher Scientific Business Overview

Table 58. Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Product

Table 59. Thermo Fisher Scientific Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024) & (US$ Million)

Table 60. Thermo Fisher Scientific Recent Development

Table 61. Intas Company Details

Table 62. Intas Business Overview

Table 63. Intas LV-Based Cell and Gene Therapy Products Product

Table 64. Intas Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024) & (US$ Million)

Table 65. Intas Recent Development

Table 66. BMS Company Details

Table 67. BMS Business Overview

Table 68. BMS LV-Based Cell and Gene Therapy Products Product

Table 69. BMS Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024) & (US$ Million)

Table 70. BMS Recent Development

Table 71. Orchard Therapeutics Company Details

Table 72. Orchard Therapeutics Business Overview

Table 73. Orchard Therapeutics LV-Based Cell and Gene Therapy Products Product

Table 74. Orchard Therapeutics Revenue in LV-Based Cell and Gene Therapy Products Business (2019-2024) & (US$ Million)

Table 75. Orchard Therapeutics Recent Development

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

Table 79. Authors List of This Report

List of Figures

Figure 1. LV-Based Cell and Gene Therapy Products Picture

Figure 2. Global LV-Based Cell and Gene Therapy Products Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global LV-Based Cell and Gene Therapy Products Market Share by Type: 2023 VS 2030

Figure 4. CAR-T Therapy Features

Figure 5. Autologous CD34+ Cell Gene Therapy Features

Figure 6. Global LV-Based Cell and Gene Therapy Products Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global LV-Based Cell and Gene Therapy Products Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Diagnostic and Testing Laboratories Case Studies

Figure 10. Academic and Research Organizations Case Studies

Figure 11. Others Case Studies

Figure 12. LV-Based Cell and Gene Therapy Products Report Years Considered

Figure 13. Global LV-Based Cell and Gene Therapy Products Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global LV-Based Cell and Gene Therapy Products Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global LV-Based Cell and Gene Therapy Products Market Share by Region: 2023 VS 2030

Figure 16. Global LV-Based Cell and Gene Therapy Products Market Share by Players in 2023

Figure 17. Global Top LV-Based Cell and Gene Therapy Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LV-Based Cell and Gene Therapy Products as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by LV-Based Cell and Gene Therapy Products Revenue in 2023

Figure 19. North America LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America LV-Based Cell and Gene Therapy Products Market Share by Country (2019-2030)

Figure 21. United States LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe LV-Based Cell and Gene Therapy Products Market Share by Country (2019-2030)

Figure 25. Germany LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific LV-Based Cell and Gene Therapy Products Market Share by Region (2019-2030)

Figure 33. China LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America LV-Based Cell and Gene Therapy Products Market Share by Country (2019-2030)

Figure 41. Mexico LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Share by Country (2019-2030)

Figure 45. Turkey LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. UAE LV-Based Cell and Gene Therapy Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Novartis Revenue Growth Rate in LV-Based Cell and Gene Therapy Products Business (2019-2024)

Figure 49. Bluebird Bio Revenue Growth Rate in LV-Based Cell and Gene Therapy Products Business (2019-2024)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in LV-Based Cell and Gene Therapy Products Business (2019-2024)

Figure 51. Intas Revenue Growth Rate in LV-Based Cell and Gene Therapy Products Business (2019-2024)

Figure 52. BMS Revenue Growth Rate in LV-Based Cell and Gene Therapy Products Business (2019-2024)

Figure 53. Orchard Therapeutics Revenue Growth Rate in LV-Based Cell and Gene Therapy Products Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Viral Vector Based Gene Therapy Drugs Market Research Report 2024

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Gene based Therapy Medicinal Market Research Report 2024

Global Cell and Gene Therapy Market Research Report 2024

Gene based Advanced Therapy Medical Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene based Advanced Therapy Medicinal Market Research Report 2025

Global AAV Vector Based Gene Therapy Drugs Market Research Report 2024

Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cellular Therapy Products Market Research Report 2024

Global Cell and Gene Therapy Services Market Research Report 2024

Lentivirus Particle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Delivery or Gene Therapy Drug Market Research Report 2025

Global High Titer Lentiviral Packaging Systems Market Research Report 2024

Cell and Gene Therapy Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Gene Therapy Market Research Report 2025

Global Gene Therapy Viral Packaging Service Market Research Report 2024

Global Viral Vector Based Gene Therapy Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions